Data Science Hub in Kenya: Innovating Health Equity

By Sumona Bose

February 25, 2024

Introduction

In a groundbreaking effort to improve health and care delivery in local communities, Aga Khan University (AKU) and the University of Michigan (U-M) have joined in partnership to establish a cutting-edge data science hub in Nairobi, Kenya. This collaborative initiative positions the power of artificial intelligence (AI) and machine learning (ML) to address health disparities and promote health equity.

Under the leadership of Joseph Kolars, director of the U-M Center for Global Health Equity, a delegation from Michigan recently visited AKU’s Nairobi campus to review the progress of their partnership. The meetings focused on the achievements since the signing of a memorandum of understanding (MOU) and provided updates on the Utilising Health Information for Meaningful Impact in East Africa through Data Science (UZIMA-DS) grant, which the institutions received two years ago.

A Collaborative Approach to Health Equity

The UZIMA-DS grant, amounting to $6.5 million, aims to establish a state-of-the-art data science hub that leverages AI, machine learning, and other emerging technologies to enhance health and care delivery in local communities. During the visit, project leads shared their progress and discussed the future of the initiative. This opportunity was a timely window to explore how both institutions can discuss challenges and find constructive routes to addressing them.

AI in Action: Looking at the Future of Healthcare

The collaboration between AKU and U-M extends beyond the UZIMA-DS grant. The visit also allowed for discussions on the new grant which supports pilot work for the Longitudinal Study of Health and Aging in Kenya (LOSHAK). This study aims to enrol thousands of Kenyan adults aged 45 and older, focusing on areas such as Alzheimer’s disease, mental health, the health and economic impacts of climate change and air pollution, and factors influencing late life economic wellbeing.

The success of this visit highlights the commitment of both institutions to advancing health equity through innovative research and collaboration. By leveraging the power of AI and machine learning, AKU and U-M are paving the way for transformative advancements in healthcare delivery, ultimately improving the lives of individuals and communities in Kenya and beyond.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.